CytomX Therapeutics Inc CTMX

NAS: CTMX | ISIN: US23284F1057 30/04/2025

0,744 USD (+14,23%)

(+14,23%) 30/04/2025

Grafiek CytomX Therapeutics Inc

Grafiek CytomX Therapeutics Inc

1 dag1d 14,23%
1 week1w -2,81%
1 maand1m 28,33%
3 maanden3m -11,40%
6 maanden6m -29,11%
1 jaar1j -85,49%
5 jaar5j -93,36%

CytomX Therapeutics Inc in het nieuws

Toon enkel gratis nieuws

17 november 2022 · Regeneron and CytomX Announce Strategic Research Collaboration in the Field of Conditional Bispecific Therapeutics for the Treatment of Cancer · Persbericht

24 februari 2021 · CytomX Therapeutics Announces Fourth Quarter and Full Year 2020 Financial Results and Provides Business Update · Persbericht

22 februari 2021 · CytomX Therapeutics to Present at Upcoming March Virtual Investor Conferences · Persbericht

19 februari 2021 · CytomX Therapeutics Announces New Employment Inducement Grant · Persbericht

3 februari 2021 · UPDATE - CytomX Therapeutics Announces Full Exercise of Underwriters’ Option to Purchase Additional Shares · Persbericht

3 februari 2021 · CytomX Therapeutics Announces Full Exercise of Underwriters’ Option to Purchase Additional Shares · Persbericht

21 januari 2021 · CytomX Therapeutics Announces Pricing of $100 Million Public Offering of Common Stock · Persbericht

19 januari 2021 · CytomX Therapeutics Announces Proposed Public Offering of Common Stock · Persbericht

7 januari 2021 · CytomX Therapeutics to Present at the 39th Annual J.P. Morgan Healthcare Conference · Persbericht

Profiel CytomX Therapeutics Inc

Fabricage van farmaceutische preparaten

Gezondheidstechnologie

Website: cytomx.com

Hoofdzetel: South San Francisco, California Verenigde Staten

CEO: Sean McCarthy

Werknemers: 157

Mijn selecties

Je selectie is nog leeg.

Voeg nu effecten toe